A variety of chromosomal alterations, including mutations, copy number changes and allelic losses, in combinations of multiple genetic signatures, have been linked to bladder cancer such as changes in FGFR3, activation of cellular signaling in PI3K, MAPK and WNT pathways, or dysregulation of genes involved in cell cycle43. This evidence concerns the gene FGFR3 and urinary bladder cancer.